valeant pharmaceuticals

Valeant Pharmaceuticals International v. Jerney Case Brief Summary | Law Case Explained

2:44

The Rise and Fall of Valeant Pharmaceuticals: Business Case Study Explained

7:28

The Valeant Fraud Explained

11:27

From Darling to Scandal: The Valeant Pharmaceuticals Story

2:23

Valeant Pharmaceuticals in crosshairs of U.S. Congress

2:30

Citron Research Founder: What Valeant's Doing 'Sounds Illegal'

4:05

Valeant changes name to Bausch Health Companies, CEO explains why

4:42

Here’s What Valeant Pharmaceuticals Said on Its Emergency Conference Call to Investors

1:14

Key things investors need to know about Valeant | The Bottom Line

2:19

Valeant Says It's Under Investigation by SEC

2:17

A Valeant Tug of War

3:57

Valeant Scandal: How Valeant Scammed People Legally | Beyond Wonder

4:31

Valeant: Damaged Goods or Deeply Discounted Drug Company?

18:40

Valeant CEO on Drug Price Hikes: We Made Mistakes

1:49

Valeant shares continue to plunge

2:03

Valeant Suffers Biggest Drop on Record, What's Next?

3:06

New To Valeant? Here's What Happened

4:03

Bill Ackman defends Valeant

5:03

Charlie Munger: Sewer too light a word for Valeant

4:38

One year later, Chanos is still shorting Valeant

1:17

Valeant

3:25

Ackman: Plan to Discuss Drug Prices With Valeant Board

2:10

Pharma CEO Admits: Our Business is Profit, Not Helping Sick People

3:14

Horizon Pharma CEO: Not A Mini-Valeant | Mad Money | CNBC

7:04

Valeant's Response to Fraud Claim Is 'Amateurish, Citron Founder Says

1:59

Nestle gets deeper into dermatology with Valeant deal - economy

00:36

Valeant Pharmaceuticals International Marks World Sight Day at the NYSE

1:06

Valeant Pharmaceuticals, Artis Reit, Boyd Group Income Fund - BNN

7:09

Bill Ackman Sells Valeant Stake After $2.8 Billion Loss

2:50

Jublia

5:15

A tumultuous year for Valeant Pharmaceuticals

1:10

Ackman: Allergan tried to 'malign' Valeant with false statements

00:58

Valeant CEO Joseph Papa: Turning Things Around | Mad Money | CNBC

9:16

Forensic Talk; NetFlix “Dirty Money” Valeant Drugs

46:44

Safkhet Capital's Quadir Is Still Short Valeant

7:39

Valeant Pharmaceuticals / Drug Price Profiteering

4:10

Valeant Pharmaceuticals CEO Returns, But Company Postpones Release of Q4 Results

1:13

Controversial Valeant-linked pharmacy closing its doors

6:49

The Valeant Disaster And Why I Switched To Trend Following

8:24

Short-Seller Quadir Makes the Bear Case for Tesla

4:31

Valeant Pharmaceuticals Shares Tank on Weak Guidance

1:17

Big shake up at Valeant

1:57

Short Seller Famous for Bet Against Valeant Targets Tesla

2:47

Analysts Eye Valeant Pharmaceuticals as Much-Anticipated Earnings Set for Release

00:59

M&A's Hard Lessons Learned From 3G, Valeant & SoftBank

1:57

Siliq

19:14

SBU MBA 610 Project - Valeant Pharmaceuticals

28:10

Zovirax ointment

6:14

Zovirax Ointment

7:08

GlaxoSmithKline, Valeant Pharma Receive EU Approval For Seizure Drug

00:39

Elizabeth Warren At Valeant Pharmaceuticals Hearing on Business Practices

7:04

Valeant May Once Again Need to Lower Its 2016 Earnings Outlook

1:06

Casey Questions Valeant Execs on Dramatic Drug Price Increases

10:34

Valeant Pharmaceuticals Misses Earnings Estimates but Posts Better-Than-Expected Guidance

1:31

Former Valeant and Philidor Executives Charged In Manhattan For Illegal Fraud And Kickback Scheme

11:57

Conference Call Scheduled Today for Valeant Pharmaceuticals

1:40

VALEANT PHARMACEUTICALS INTERNATIONAL INC. - Lauréat régional 2016 - Laval

3:42

Here's Why Shares of Valeant are Higher in Monday's Trading Session

00:50

A timeline of Valeant’s fall from the top

1:32

What Jim Cramer Thinks About Valeant Pharmaceuticals Shares

00:38